Fiche personne


Territoire

Bourgogne

Statut

Hospitalier

Publications


Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

Valderrama NF, Morel LO, Mweze DT, Derangère V, Desmoulins I, Mayeur D, Kaderbhai C, Ilie S, Hennequin A, Roussot N, Bergeron A, Beltjens F, Pescia C, Morel HP, Coutant C, Rittscher J, Arnould L, Vinçon N, Ladoire S

Eur J Cancer. 2026 01 7;234:116222

Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study.

Samalin E, Evesque L, Turpin A, De La Fouchardiere C, Khemissa-Akouz F, Bouché O, Muller M, Dermeche S, Botsen D, Tougeron D, Zaanan A, Ben Abdelghani M, Guardiola E, Dubreuil O, Le Brun Ly V, Hennequin A, Watson S, Sefrioui D, Lecomte T, De Sousa Carvalho N, Hulin A, Crapez E, Castan F, Senellart H

ESMO Open. 2025 05 12;10(5):105096

Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.

Llombart-Cussac A, Harper-Wynne C, Perelló A, Hennequin A, Fernández-Ortega A, Colleoni M, Marín S, Quiroga V, Medioni J, Iranzo V, Wheatley D, Del Barco Berrón S, Antón A, Dobi E, Ruiz-Borrego M, Alcalá-López D, Pérez-Escuredo J, Antonarelli G, Sampayo-Cordero M, Pérez-García JM, Cortés J

J Clin Oncol. 2025 04 28;:JCO2401865

Voir plus